Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Source: Eur Respir J 2006; 27: 957-963 Year: 2006
Platelet-derived growth factor levels in sputum of patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 423s Year: 2002
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006
Airway epithelial cells from asymptomatic smokers but not from smokers with chronic bronchitis and COPD have increased C/EBP transcription factor activity Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002
Sputum VEGF level increases with treatment of COPD acute exacerbation Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012
Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001
Increased tissue factor in bronchial biopsies from patients with severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 37s Year: 2003
Expression of epidermal growth factor receptor (EGFR) in the bronchial epithelium of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
Decrease of vascular endothelial growth factor in macrophages from long-term smokers Source: Eur Respir J 2005; 25: 626-633 Year: 2005
Factors influencing induced sputum cytokines and VEGF in a population of stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006
High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis Source: ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020 Year: 2021
Leptin levels in induced sputum from patients with COPD are sensitive to smoking status Source: Eur Respir J 2005; 26: Suppl. 49, 660s Year: 2005
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005
Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Higher interleukin-6 levels and changes in transforming growth factor-ß are associated with lung impairment in pulmonary tuberculosis Source: ERJ Open Res, 7 (1) 00390-2020; 10.1183/23120541.00390-2020 Year: 2021
Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis Source: Eur Respir J 2015; 46: 1501-1503 Year: 2015
Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity Source: Eur Respir J 2003; 21: 842-847 Year: 2003